ArticleJournal of the advanced practitioner in oncology

Gilteritinib: A Novel FLT3 Inhibitor for Relapsed/Refractory Acute Myeloid Leukemia.

Dennis Marjoncu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.